The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Similarities in treatment (Tx) patterns and clinical outcomes (CO) in patients (pts) with metastatic colorectal cancer (mCRC) initially treated with FOLFOX/BV or FOLFIRI/BV: Results from ARIES, a bevacizumab (BV) observational study.
Johanna C. Bendell
Disclosure not yet available
Tanios S. Bekaii-Saab
Disclosure not yet available
Allen Lee Cohn
Disclosure not yet available
Herbert Hurwitz
Disclosure not yet available
Mark Kozloff
Disclosure not yet available
Haluk Tezcan
Disclosure not yet available
Shibao Feng
Disclosure not yet available
Elizabeth Dawn Flick
Disclosure not yet available
Amy Sing
Disclosure not yet available
Axel Grothey
Disclosure not yet available